US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Oncosil Medical Ltd (OSL) 銘柄情報

Oncosil Medical Ltd (OSL)

0.435

0.00

(0.00%)

終了 6月8日 3:00PM

Oncosil Medical Ltd (OSL) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.435

( - )

買値

0.435

売値

0.435

出来高

0.00

0.00 日の範囲 0.00

0.37 52 週間の範囲 2.09

時価総額

前日終値

0.435

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 90,282

発行済株式数

30,697,231

配当利回り

PER

-0.57

1 株当たり利益 (EPS)

-0.85

歳入

3.72M

純利益

-12.92M

OncoSil Medical Limited, a medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The company’s lead product is OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancr... OncoSil Medical Limited, a medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The company’s lead product is OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

www.oncosil.com

本社

Macquarie Park, Australia

設立

2026

Oncosil Medical Ltd is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker OSL. The last closing price for Oncosil Medical was AUD0.44. Over the last year, Oncosil Medical shares have traded in a share price range of AUD 0.37 to AUD 2.09.

Oncosil Medical currently has 30,697,231 shares in issue. The market capitalisation of Oncosil Medical is AUD13.35 million. Oncosil Medical has a price to earnings ratio (PE ratio) of -0.57.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.05	-10.3092783505	0.485	0.515	0.43	104340	0.46163988	DE
4	-0.065	-13	0.5	0.65	0.37	203079	0.48990483	DE
12	-0.155	-26.2711864407	0.59	0.65	0.37	101105	0.49562487	DE
26	-0.68	-60.9865470852	1.115	1.115	0.37	69133	0.57737217	DE
52	-0.515	-54.2105263158	0.95	2.09	0.37	50463	0.7981611	DE
156	0.422	3246.15384615	0.013	2.09	0.0025	2988179	0.01255369	DE
260	0.37	569.230769231	0.065	2.09	0.0025	2483205	0.02093425	DE

OSL - Frequently Asked Questions (FAQ)

What is the current Oncosil Medical Ltd share price?

The current share price of Oncosil Medical Ltd is AUD 0.435

How many Oncosil Medical Ltd shares are in issue?

Oncosil Medical Ltd has 30,697,231 shares in issue

What is the market cap of Oncosil Medical Ltd?

The market capitalisation of Oncosil Medical Ltd is AUD 13.35M

What is the 1 year trading range for Oncosil Medical Ltd share price?

Oncosil Medical Ltd has traded in the range of AUD 0.37 to AUD 2.09 during the past year

What is the PE ratio of Oncosil Medical Ltd?

The price to earnings ratio of Oncosil Medical Ltd is -0.57

What is the cash to sales ratio of Oncosil Medical Ltd?

The cash to sales ratio of Oncosil Medical Ltd is 4

What is the registered address of Oncosil Medical Ltd?

The registered address for Oncosil Medical Ltd is 7 Eden Park Drive, Macquarie Park, New South Wales, 2113

What is the Oncosil Medical Ltd website address?

The website address for Oncosil Medical Ltd is www.oncosil.com

Which industry sector does Oncosil Medical Ltd operate in?

Oncosil Medical Ltd operates in the Medical Equipment & Supplies sector

BeachBum

BeachBum 1分前

If they don’t dilute, this is a market cap play.

BeachBum

BeachBum 1分前

If they don’t dilute, this is a market cap play.

nowwhat2

nowwhat2 2分前

It's an exceedingly complex (and high stakes) endeavor.

The nuances of which virtually no one can grasp and it's going to take over a decade to resolve.

Starting when ? Starting from Bitcoins' (and cryptos) inception.

https://investorshub.advfn.com/uimage

US Market News

US Market News 5分前

New IBM Study Finds CIOs and CTOs Face Growing AI Control Gap as Enterprise Deployment ScalesJune 8, 2026 12:01 AM
PR Newswire (US) Most surveyed technology leaders are accountable for systems they don't fully controlOnly 11% o

Plato_

🎁 A gift from Plato! 😎https://investorshub.advfn.com/uimage/uploads/2026/6/8/trfmgcagr_circles_-_Copy.png

3331

BIEL PPS-Acceleration Actions To Help Electrome
The Billion-Dollar Pattern Playing Out Right Now: BIEL / Electrome (BIEL)
If you’ve been in the retail trading space for the last decade, you’ve watched the exact same script play out across GME, AMC, Tesla, Palantir, and NIO.

MarkMonkey

MarkMonkey 17分前

You may buy or sell a position at any time? Wow! That makes you exactly the same as every single person that has ever invested on the stock market. Thanks for the heads up, all of us will eagerly be awaiting and watching to see if you buy or sell a position. We are on edge! Will it be a BUY or a SEL

flushes

flushes 17分前

At this point I've resigned myself to the thought that my investment is gone. Was only 5k cdn so not totally a huge loss but enough. Lesson here is that anything OTC is a gamble. I bet red. I lost. See you around.

US Market News

US Market News 20分前

BitGo MENA Launches Regulated Electronic Trading, Delivering Full Suite Trading Services to the RegionJune 8, 2026 12:00 AM
Business Wire BitGo MENA FZE (“BitGo MENA”), a subsidiary of BitGo Holdings, Inc. (NYSE: BTGO) (“BitGo”), the digital asset infrastructure company, today

Genz2

Methinks, to be honest with you, one of the things that makes me nervous about SKS is he is carrying extra weight and I want him to live a long time!!! With these miracle weight loss drugs, I wonder if he has tried one?! Concerned in Connecticut. Anyway, they should just get rid of this mess with

okpj

Hopefully mid .20’s this week.
That would exceed any expectations I have, but I will not complain.

dh_

Just found this article which helps explain the value of Ultranet for IQSTEL, that is, other than the obvious boost in margins and large contribution towards achieving positive net income for the entire company. Keep scrolling down as it has breaks in the text.

https://af

mrwrn2010

mrwrn2010 31分前

True on Vyvanse, BUT Vyvanse has some structural advantages for us:

-Vyvanse is a controlled substance (DEA sets a ceiling on the supply, each company has to battle for their allotment of quota and the better managing companies take market share)

-It and the Adderalls h

HGiLS

You are right about one thing only: I will be paid the day of the buyout just by holding my 3 million shares.

You talk bs because you don’t understand big numbers and the dynamics of real world genetics revenues attrition

Eli's Gone

Eli's Gone 39分前

I wait until Mon/Tues to see what's out there

mrwrn2010

mrwrn2010 41分前

Put me down for A.

B probably gets us a higher price down the line but after waiting how much longer?

MasterBlastr

MasterBlastr 44分前

I see there is a $250K Drive the Green [$30K to 1st] taking entries already. I think they have more than one of these $5 contests each week, with differing payouts. Is the $250K the one you plan on entering next week, otherwise I will wait for the $350K.

Miamifl

Miamifl 50分前

If an individual or Poster on this board is NOT in adherence to Rule 10b-5 of the Securities Exchange Act, then I think I or someone on this board should call the company and inform them of what is happening. THEY have their own Legal Counsel that can investigate this and take action against the ind

EarningsCentral

EarningsCentral 52分前

EarningsCentral

EarningsCentral 54分前

MasterBlastr

MasterBlastr 58分前

I'll hold it for you . .

Truenorth2016

Truenorth2016 59分前

Value Investing is Buying Stocks like BIEI that is Ignored, Underfollowed, Out Of Favor, (For Now) and Misunderstood!! All that is about to change!! What BIEI has going on many never seen in OTC before and its hard for them to comprehend this little .0011 Cent Stock has access to Military Defense Le

Eli's Gone

Eli's Gone 1時間前

I usually stuff a placeholder team in and go back in and change it...

Oncosil Medical

Vanguard S&P 500 Growth

Vontobel Financial Produ...

Innovator Equity Defined...

Commonwealth Bank

Trillium Therapeutics

Tasman Resources

Jpmorgan Chase Financial...

Netnation Communications

RiceBran Technologies

Rock Edge Resources

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。